|
End-of-day quote
Shenzhen S.E.
2026-09-11
|
5-day change | 1st Jan Change | ||
| 33.66 CNY | -2.01% |
|
-5.42% | +0.33% |
| 09-04 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 09-04 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 15.1B 2.25B 1.94B 1.84B 1.66B 3.12B 215B 3.14B 21.81B 8.39B 109B 8.45B 8.27B 346B | P/E 2026 * |
29x | P/E 2027 * | -146x |
|---|---|---|---|---|---|
| Enterprise Value | 15.1B 2.25B 1.94B 1.84B 1.66B 3.12B 215B 3.14B 21.81B 8.39B 109B 8.45B 8.27B 346B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 12x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.01% | ||
| 1 week | -5.42% | ||
| Current month | -6.78% | ||
| 1 month | -9.22% | ||
| 3 months | -1.35% | ||
| 6 months | +3.09% | ||
| Current year | +0.33% |
| 1 week | 33.23 |  | 36.3 |
| 1 month | 33.23 | | 40.2 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 64.73 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 2015-11-10 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 2015-11-10 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 2020-12-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 2015-11-10 |
Han Dong Li
BRD | Director/Board Member | 58 | 2015-11-10 |
Liang Wen Huang
CHM | Chairman | 50 | 2015-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/5/26 | Buy | Director | 4,200 | 0.0010% | ||
| 11/24/25 | Buy | Director | 7,000 | 0.0017% | ||
| 9/1/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01% | -5.42% | -45.03% | +64.84% | 2.25B | |
| -1.13% | -3.11% | +14.31% | +61.84% | 46.21B | |
| -1.13% | -5.78% | +34.89% | +111.91% | 38.78B | |
| +0.12% | -0.08% | +7.23% | +78.04% | 11.68B | |
| -0.53% | -1.37% | -12.48% | +9.51% | 11.55B | |
| -0.38% | -2.26% | +18.18% | +136.36% | 9.14B | |
| +0.32% | -2.26% | +23.33% | +33.23% | 7.3B | |
| -1.00% | -5.25% | +33.87% | -18.63% | 7.1B | |
| +0.17% | -0.74% | +13.70% | +198.32% | 7.15B | |
| -3.13% | -4.30% | -44.48% | +13.47% | 4.97B | |
| Average | -0.87% | -2.98% | +4.35% | +68.89% | 14.61B | |
| Weighted average by Cap. | -0.87% | -3.32% | +15.79% | +76.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 161M 139M 131M 119M 223M 15.38B 224M 1.56B 600M 7.82B 605M 591M 24.72B | 1.26B 188M 162M 153M 139M 260M 17.91B 261M 1.82B 699M 9.11B 704M 689M 28.8B |
| Net income | 526M 78.41M 67.55M 63.96M 57.98M 109M 7.49B 109M 760M 292M 3.81B 294M 288M 12.04B | -102M -15.2M -13.1M -12.4M -11.24M -21.09M -1.45B -21.2M -147M -56.65M -739M -57.1M -55.85M -2.34B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | CN¥33.66 | -2.01% | 4,635,601 |
| 26-09-10 | CN¥34.35 | -1.72% | 4,167,799 |
| 26-09-09 | CN¥34.95 | -1.91% | 5,030,471 |
| 26-09-08 | CN¥35.63 | -0.95% | 6,279,493 |
| 26-09-07 | CN¥35.97 | +1.07% | 5,975,692 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
